Dr Sarah Brown

MBBS BSc MD (Res) FRCPCH

Paediatric Respiratory Consultant

Dr Sarah Brown is a Consultant Paediatrician specialising in general paediatrics and paediatric respiratory medicine.

Clinical Interests

  • Cough
  • Asthma
  • Wheezing
  • Bronchitis
  • Noisy breathing
  • Recurrent croup
  • Snoring
  • Sleep disordered breathing
  • Recurrent chest infections / bronchiectasis 
  • Cystic fibrosis
  • Primary ciliary dyskinesia
  • Bedwetting & urine infections
  • Fits, faints and funny turns
  • Headaches
  • Developmental & behavioural concerns
  • Abdominal pain (tummy ache)
  • Constipation, diarrhoea, vomiting
  • Reflux
  • Well baby/child checks
  • Growth concerns (including obesity)

Year Qualified

2000

NHS Base

Royal London Children’s Hospital, Barts Health NHS Trust

Dr Sarah Brown

MBBS BSc MD (Res) FRCPCH

Paediatric Respiratory Consultant

Professional Profile

Dr Brown qualified from Royal Free and University College Medical School, University of London in 2000, where she was also awarded a BSc in Clinical Immunology and Cell Pathology. Prior to qualification she undertook her medical school elective in Paediatric Trauma at the Red Cross Children’s Hospital, Cape Town, South Africa. It was here that she developed a passion for paediatrics and an understanding of how our childhoods shape all of us as adults – psychologically and physically.

Back in the UK she undertook training posts in London in medicine and surgery before completing a training programme in general paediatrics and neonatology. A post at the Royal Brompton Hospital proved to be a turning point, and where she commenced subspeciality training in paediatric respiratory medicine. This programme included further posts at the Royal Brompton Hospital, Great Ormond Street Hospital and the Royal London Hospital, and a 2 -year research degree at the National Heart and Lung Institute, Imperial College London. She joined the Royal London Hospital as a consultant in paediatric respiratory medicine in 2015 where she is also clinical lead for the service.

To learn more about Dr Brown’s practice, please click here.

Personal Profile

Dr Brown lives in Kent with her husband and two school-age children. In her free time she enjoys outdoor pursuits, the Arts and gardening.

Dr Sarah Brown

MBBS BSc MD (Res) FRCPCH

Paediatric Respiratory Consultant

Reviews

Below is a snapshot of some feedback for Dr Sarah Brown.

 

Dr Sarah Brown

MBBS BSc MD (Res) FRCPCH

Paediatric Respiratory Consultant

Memberships & Associations

  • General Medical Council
  • Royal College of Paediatrics and Child Health
  • British Paediatric Respiratory Society
  • British Thoracic Society
  • European Respiratory Society 
  • Member of RCPCH Health Improvement Committee
  • Honorary Senior Lecturer, Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London

Dr Sarah Brown

MBBS BSc MD (Res) FRCPCH

Paediatric Respiratory Consultant

 

Principal Investigator

 

Skyline 102 VX20-121-102 (Vertex Pharmaceuticals) IRAS 1003950 Phase 3 randomised double-blind controlled study evaluating safety of VX-121 combination therapy in subjects with cystic fibrosis who are heterozygous for F508del and a minimal function mutation (F/MF)

 Skyline 103 VX20-121-103 (Vertex Pharmaceuticals) IRAS 1003951 Phase 3 randomised double-blind controlled study evaluating safety of VX-121 combination therapy in subjects with cystic fibrosis who are homozygous for F508del (F/F)

MAGNIFY VX20-CFD-004 (Vertex Pharmaceuticals) IRAS 290795 A study on the quality of life for cystic fibrosis patients treated with Orkambi® or Symkevi® and their caregivers

 

Sub-investigator

 

Skyline 104 VX20-121-104 (Vertex Pharmaceuticals) IRAS 1005889 A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis

 4 WHIM X4P-001-103 (X4 Pharmaceuticals) Phase 3 randomised double-blind placebo-controlled multicentre study of Mavorixafor in patients with WHIM syndrome with open label extension

CF STORM NIHR / University of Liverpool IRAS 293186 A randomised open label trial to assess change in respiratory function for people with cystic fibrosis established on triple combination therapy (KaftrioTM) after rationalisation of nebulised mucoactive therapies.

CF START NIHR/ University of Liverpool The cystic fibrosis (CF) anti-staphylococcal antibiotic prophylaxis trial: a randomised registry trial to assess the safety and efficacy of flucloxacillin as a long-term prophylaxis agent for infants with CF

VX20-CFD-005 TRAJECTORY (Vertex Pharmaceuticals) A longitudinal study on the impact of ELX/TEZ/IVA treatment in patients with cystic fibrosis in the real world

Clinical Research Fellow Imperial College London (Leukocyte Biology) / Royal Brompton Hospital 2009-2011. Supervisors: Prof C Lloyd, Prof A Bush and Prof J Davies. 

Thesis “Mechanisms of resolution of inflammation in paediatric inflammatory lung disease” – and awarded MD (res) in 2015.

 

For more information, please click here.

Hospital Information

Hospital: One Ashford Hospital

Tel: 01233 423 000

Contact the Hospital
Contact the Hospital About Dr Sarah Brown
  • This field is for validation purposes and should be left unchanged.

Dr Sarah Brown offers the following treatments and procedures:

Asthma